Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 15, Issue 10, Pages 1233-1255
Publisher
Informa UK Limited
Online
2015-09-25
DOI
10.1586/14737140.2015.1086647
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted nanoscale magnetic hyperthermia: challenges and potentials of peptide-based targeting
- (2015) Daniel Fourmy et al. Nanomedicine
- Efficacy and tolerability of 1- and 3-month leuprorelin acetate depot formulations (Eligard ® /Depo-Eligard ® ) for advanced prostate cancer in daily practice: a Belgian prospective non-interventional study
- (2014) Johan Braeckman et al. Archives of Medical Science
- Nanodrugs: pharmacokinetics and safety
- (2014) Satomi Onoue et al. International Journal of Nanomedicine
- Nanopharmaceuticals (part 1): products on the market
- (2014) Volkmar Weissig et al. International Journal of Nanomedicine
- Infrared-Transparent Gold Nanoparticles Converted by Tumors to Infrared Absorbers Cure Tumors in Mice by Photothermal Therapy
- (2014) James F. Hainfeld et al. PLoS One
- Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives
- (2014) Guang-Xia Chen et al. OncoTargets and Therapy
- Perspectives of Breast Cancer Thermotherapies
- (2014) Edouard Alphandéry Journal of Cancer
- A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
- (2013) A H Ko et al. BRITISH JOURNAL OF CANCER
- Efficacy and safety of pegylated-interferon α-2a in myelofibrosis: a study by the FIM and GEM French cooperative groups
- (2013) Jean-Christophe Ianotto et al. BRITISH JOURNAL OF HAEMATOLOGY
- Nanooncology: The future of cancer diagnosis and therapy
- (2013) Avnesh S. Thakor et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ECOG Phase II Trial of Graded-Dose Peginterferon -2b in Patients with Metastatic Melanoma Overexpressing Basic Fibroblast Growth Factor (E2602)
- (2013) R. S. Go et al. CLINICAL CANCER RESEARCH
- High-dose Vincristine Sulfate Liposome Injection (Marqibo) Is Not Associated With Clinically Meaningful Hematologic Toxicity
- (2013) Olivia R. Deitcher et al. Clinical Lymphoma Myeloma & Leukemia
- Phase II Study of Vincristine Sulfate Liposome Injection (Marqibo) and Rituximab for Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma in Need of Palliative Therapy
- (2013) Lawrence D. Kaplan et al. Clinical Lymphoma Myeloma & Leukemia
- Use of bacterial magnetosomes in the magnetic hyperthermia treatment of tumours: A review
- (2013) Edouard Alphandéry et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
- (2013) Glen J. Weiss et al. INVESTIGATIONAL NEW DRUGS
- Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group
- (2013) Gertjan J.L. Kaspers et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle
- (2013) S. Eliasof et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin
- (2013) Mehmet H Ucisik et al. JOURNAL OF NANOBIOTECHNOLOGY
- Challenges in Development of Nanoparticle-Based Therapeutics
- (2012) Neil Desai AAPS Journal
- The effect of iron-chelating agents on Magnetospirillum magneticum strain AMB-1: stimulated growth and magnetosome production and improved magnetosome heating properties
- (2012) Edouard Alphandéry et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies
- (2012) Sameer Agnihotri et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Vincristine Sulfate Liposome Injection
- (2012) Tracy S. Harrison et al. BIODRUGS
- Nanoscale radiotherapy with hafnium oxide nanoparticles
- (2012) Laurence Maggiorella et al. Future Oncology
- Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia
- (2012) Edouard Alphandéry et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts
- (2012) Pin-Yuan Chen et al. NEURO-ONCOLOGY
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Surface Engineering of Iron Oxide Nanoparticles for Targeted Cancer Therapy
- (2011) Forrest M. Kievit et al. ACCOUNTS OF CHEMICAL RESEARCH
- Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine
- (2011) Elizabeth A. Vasievich et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Curcumin nanoformulations: a future nanomedicine for cancer
- (2011) Murali M. Yallapu et al. DRUG DISCOVERY TODAY
- A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer
- (2011) D. Amadori et al. EUROPEAN JOURNAL OF CANCER
- Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101
- (2011) Sonke Svenson et al. JOURNAL OF CONTROLLED RELEASE
- Administration, distribution, metabolism and elimination of polymer therapeutics
- (2011) Ela Markovsky et al. JOURNAL OF CONTROLLED RELEASE
- Chains of Cobalt Doped Magnetosomes Extracted from AMB-1 Magnetotactic Bacteria for Application in Alternative Magnetic Field Cancer Therapy
- (2011) E. Alphandéry et al. Journal of Physical Chemistry C
- Selective nanoparticle-directed ablation of the canine prostate
- (2011) Jon A. Schwartz et al. LASERS IN SURGERY AND MEDICINE
- Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma
- (2011) S M Ansell et al. LEUKEMIA
- Future of nanomedicine: obstacles and remedies
- (2011) Rita Bosetti et al. Nanomedicine
- Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer
- (2011) Shikha Gaur et al. Nanomedicine-Nanotechnology Biology and Medicine
- Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
- (2010) S. K. Libutti et al. CLINICAL CANCER RESEARCH
- Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting
- (2010) Melanie B. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
- (2010) Klaus Maier-Hauff et al. JOURNAL OF NEURO-ONCOLOGY
- Heat Production by Bacterial Magnetosomes Exposed to an Oscillating Magnetic Field
- (2010) E. Alphandéry et al. Journal of Physical Chemistry C
- Tracking of Multimodal Therapeutic Nanocomplexes Targeting Breast Cancer in Vivo
- (2010) Rizia Bardhan et al. NANO LETTERS
- Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma
- (2010) James F Hainfeld et al. PHYSICS IN MEDICINE AND BIOLOGY
- Different signatures between chemically and biologically synthesized nanoparticles in a magnetic sensor: A new technology for multiparametric detection
- (2010) E. Alphandéry et al. SENSORS AND ACTUATORS B-CHEMICAL
- Use of Tumor Necrosis Factor–alpha-coated Gold Nanoparticles to Enhance Radiofrequency Ablation in a Translational Model of Renal Tumors
- (2010) Renato Nardi Pedro et al. UROLOGY
- Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial
- (2009) S. Luminari et al. ANNALS OF ONCOLOGY
- Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)
- (2009) R.C.F. Leonard et al. BREAST
- Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma
- (2009) M. A. Rodriguez et al. CANCER
- Phase I study of non-pegylated liposomal doxorubicin in combination with ifosfamide in adult patients with metastatic soft tissue sarcomas
- (2009) Elisa Stroppa et al. INVESTIGATIONAL NEW DRUGS
- Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients
- (2008) Andrea Camera et al. ANNALS OF HEMATOLOGY
- The addition of liposomal doxorubicin to bortezomib, thalidomide and dexamethasone significantly improves clinical outcome of advanced multiple myeloma
- (2008) Stefania Ciolli et al. BRITISH JOURNAL OF HAEMATOLOGY
- Liposomal daunorubicinversusstandard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia
- (2008) Roberto Latagliata et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pegfilgrastim; a neutrophil mediated granulocyte colony stimulating factor–expanding uses in cancer chemotherapy
- (2008) Mariko Morishita et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Pegasparaginase: where do we stand?
- (2008) Amer Zeidan et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Radiotherapy enhancement with gold nanoparticles
- (2008) James F. Hainfeld et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma
- (2008) Paul L. R Mitchell et al. LEUKEMIA & LYMPHOMA
- Modulation of in Vivo Tumor Radiation Response via Gold Nanoshell-Mediated Vascular-Focused Hyperthermia: Characterizing an Integrated Antihypoxic and Localized Vascular Disrupting Targeting Strategy
- (2008) Parmeswaran Diagaradjane et al. NANO LETTERS
- Emerging nanopharmaceuticals
- (2008) Willie E. Bawarski et al. Nanomedicine-Nanotechnology Biology and Medicine
- Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
- (2008) F. Gu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective Prostate Cancer Thermal Ablation With Laser Activated Gold Nanoshells
- (2007) Joshua M. Stern et al. JOURNAL OF UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started